ethinyl estradiol-norgestrel combination has been researched along with levonorgestrel in 122 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (10.66) | 18.7374 |
| 1990's | 9 (7.38) | 18.2507 |
| 2000's | 15 (12.30) | 29.6817 |
| 2010's | 79 (64.75) | 24.3611 |
| 2020's | 6 (4.92) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JK; Fan, BC; Fotherby, K; He, ML; Li, LM; Rekers, H; Song, S; Yang, PJ | 1 |
| Brandstädt, A; Carol, W; Jäger, R; Kasch, R; Klinger, G | 1 |
| Laine, M; Ojanotko-Harri, A; Pienihäkkinen, K; Tenovuo, J | 1 |
| Chiang, ST; Lobo, RA; Stanczyk, FZ; Woutersz, TB | 1 |
| Kamau, RK; Kigondu, C; Maina, FW; Mati, JK | 1 |
| Garcia-Bragado, F; Grilo, A; Iriarte, LM; Lozano, F; Rivera, JM; Salgado, V | 1 |
| Mall-Haefeli, M | 1 |
| Hale, R | 1 |
| Back, DJ; el-Raghy, I; Fathalla, M; Makeram, M; Orme, ML; Osman, F; Salem, H | 1 |
| Albus, C; Männchen, E | 1 |
| Klove, KL; Lobo, RA; Roy, S | 1 |
| Deville, JL; Dubois, M; Gaspard, UJ | 1 |
| Allen, WL; Back, DJ; Breckenridge, AM; Grimmer, SF; Orme, M; Tjia, J | 1 |
| Diczfalusy, E; Landgren, BM | 1 |
| el-Kabsh, MY; Elwan, SI; Farghaly, SA; Shaaban, MM; Thabet, N | 1 |
| Ahren, T; Akinla, O; Alvarez-Sanchez, F; Brache, V; Brenner, PF; Coutinho, E; Darze, E; Diaz, J; Diaz, S; Fasan, MO; Faundes, A; Gama daSilva, JC; Giwa-Osagie, OF; Jackanicz, TM; Mishell, DR; Nash, HA; Nielsen, NC; Pavez, M; Pyorala, T; Roy, S; Sivin, I; Stern, J; Victor, A; Zausner-Guelman, B | 3 |
| Hau, J; Nielsen, CH; Poulsen, HK; Teisner, B; Thorsen, P; Westergaard, JG | 1 |
| Berenson, AB; Wiemann, CM | 1 |
| Kondrikov, NI; Nazarova, NM; Prilepskaia, VN | 1 |
| Aguayo, EL; Calventi, V; de Silva, P; Dunson, TR; Gerais, AS; McLaurin, VL; Serani, RG | 1 |
| Mueck, AO; Petersen, G; Schulte-Wintrop, E; Seeger, H; Wallwiener, D | 1 |
| Bloom, LI; Kaptain, S; Weir, MM | 1 |
| Grimes, DA; Helmerhorst, FM; Schulz, KF; van Vliet, HA | 1 |
| Janik, F; Levy, RH; Ragueneau-Majlessi, I | 1 |
| Anderson, FD; Hait, H | 1 |
| Sarkar, NN | 1 |
| Fan, A; Yang, F; Zhang, M; Zhou, G; Zhou, S; Zhu, L | 1 |
| Ensom, MH; Fielding, DW; Levine, M; Osmond, BL; Soon, JA | 1 |
| Chowdary, GV; Murthy, JM; Narayanan, TJ | 1 |
| Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA | 1 |
| Richardson, MK | 1 |
| Scheinfeld, N | 1 |
| Freeman, SB | 1 |
| Hait, H; Kaunitz, AM; Portman, DJ; Reape, KZ | 1 |
| Ahrendt, HJ; Makalová, D; Mansour, D; Mellinger, U; Parke, S | 1 |
| Leung, VW; Levine, M; Soon, JA | 1 |
| Carter, R; Davies, E; Fearns, S; Gerlinger, C; Kelly, S; McKinnon, C; Smithers, A | 1 |
| Höschen, K; Röhm, P; Winkler, UH | 1 |
| Cartwright, B; Robinson, J; Rymer, J | 1 |
| El-Nashar, SA; Sayed, GH; Shaaban, MM; Zakherah, MS | 1 |
| Hindsberger, C; Jacobsen, LV; Vouis, J; Zdravkovic, M | 1 |
| Friedrich, C; Giessmann, T; Graefe-Mody, U; Iovino, M; Port, A; Ring, A; Woerle, HJ | 1 |
| Junge, W; Mellinger, U; Parke, S; Serrani, M | 1 |
| Belcaro, G; Cesarone, MR; Finco, A | 1 |
| Carlson, NE; Edelman, A; Forbes, MM; Jensen, J; Kaneshiro, B; Nichols, M | 1 |
| Beasley, A; Estes, C; Guerrero, J; Westhoff, C | 1 |
| Mayeda, ER; Pike, MC; Shimoni, N; Stanczyk, FZ; Torgal, AT; Westhoff, CL | 1 |
| Constantine, GD; Freeman, EW; Grubb, GS; Halbreich, U; Mirkin, S; Rapkin, AJ; Skouby, SO; Smith, L | 1 |
| Cherala, G; Edelman, A; Elman, MR; Koop, D; Munar, M | 1 |
| Burggraaf, J; Cohen, AF; de Kam, ML; Kluft, C; Rad, M | 1 |
| Anzures-Cabrera, J; Derks, M; Young, A | 1 |
| Chong, CL; Davis, J; Langdon, G; Layton, G; Ndongo, MN; Vourvahis, M | 1 |
| Corthout, J; De Braekeleer, K; Vanheusden, V | 1 |
| Franceschini, SA; Fumagalli, HF; Martinez, EZ; Marzocchi-Machado, CM; Stocco, B; Toloi, MR | 1 |
| David, OJ; den Daas, I; Emotte, C; Jakab, A; Meiser, K; Ocwieja, M; Schmouder, R; Wemer, J | 1 |
| Cherala, G; Dubois, B; Edelman, AB; Jensen, JT; McInnis, M; Munar, MY; Stanczyk, FZ | 1 |
| Aggarwal, A; Bernardin, J; Burnett, M; Clark, V; Davis, V; Dempster, J; Dunn, S; Fisher, W; Guilbert, É; MacKinnon, K; Pellizzari, R; Polomeno, V; Rutherford, M; Sabourin, J; Senikas, V; Wagner, MS | 1 |
| Graham, CA; Panicker, S; Shawe, J; Stephenson, J | 1 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
| Akintomide, H; Brima, N; Copas, A; O'Brien, P; Panicker, S; Sauer, U; Shawe, J; Stephenson, J; Wilkinson, C | 1 |
| Bitzer, J; Davis, SR; Giraldi, A; Mellinger, U; Nappi, RE; Palacios, S; Parke, S; Serrani, M | 1 |
| Cherala, G; Edelman, A; Maslen, C; Pearson, J | 1 |
| Rolan, P; Stockis, A | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Rubin, A; Westhoff, CL | 1 |
| Bond, M; Darwish, M; Fiedler-Kelly, J; Grasela, T; Hsieh, J; Ricciotti, N | 1 |
| Ichida, K; Motoyama, S; Murakoshi, H; Okada, J; Yasuda, R; Yokoyama, N; Yoshida, S | 1 |
| Mellinger, U; Parke, S; Petraglia, F; Römer, T; Serrani, M | 1 |
| Berretti, R; Concas, A; Locci, A; Porcu, P; Santoru, F | 1 |
| Benjamin, E; Conway, GS; McGregor, D; Olaitan, A; Saridogan, E; Swamy, A | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR | 1 |
| Dienel, A; Heger-Mahn, D; Klipping, C; Pabst, G; Schläfke, S | 1 |
| Bernard, A; Devineni, D; Mamidi, RN; Manitpisitkul, P; Rothenberg, P; Sha, S; Skee, D; Stieltjes, H; Tian, H; Vaccaro, N; Weiner, S | 1 |
| Elgadi, M; Huang, F; Lang, B; Sabo, JP | 1 |
| Bangerter, K; Kroll, R; Lynen, R; Merz, M | 1 |
| Fraser, IS; McGeechan, K; Merki-Feld, GS; Weisberg, E | 1 |
| Flint, A; Hartvig, H; Jensen, CB; Jensen, L; Kapitza, C; Nosek, L | 1 |
| Cremers, S; DiNapoli, MN; Pike, MC; Sull, M; Tang, R; Westhoff, CL | 1 |
| Howard, B; Kroll, R; Ricciotti, N; Seidman, L; Weiss, H | 1 |
| Butler, K; Dietz Ostergaard, S; Johnson, R; Kersh, EN; Lathrop, G; McNicholl, JM; Powell, N; Ritter, JM; Sanders, J; Zaki, SR | 1 |
| El-Haggar, SM; Mostafa, TM | 1 |
| Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Westhoff, CL | 2 |
| Collomp, K; Jaffré, C; Lasne, F; Rieth, N; Vibarel-Rebot, N | 1 |
| Bhansali, S; Chen, J; Majumdar, T; Meyers, C; Neelakantham, S; Rebello, S; Sunkara, G; Trusley, C | 1 |
| Howard, B; Hsieh, J; Kroll, R; Ricciotti, N; Seidman, L; Weiss, H | 1 |
| Chakraborty, A; Jakab, A; Legangneux, E; Mensinga, T; Neelakantham, S; Rouzade-Dominguez, ML; Sivasubramanian, R; Ufer, M; Woessner, R | 1 |
| Chabbert-Buffet, N; Jamin, C; Lello, S; Lete, I; Lobo, P; Nappi, RE; Pintiaux, A | 1 |
| Burness, CB | 1 |
| Giljanovic, S; Howard, B; Lobo Abascal, P; Luzar-Stiffler, V; Trussell, J; Weiss, H | 1 |
| Archer, DF; Sriprasert, I; Stanczyk, FZ | 1 |
| Bannbers, E; Engman, J; Frick, A; Gingnell, M; Moby, L; Sundström-Poromaa, I; Wikström, J | 1 |
| Akahori, M; Dahlke, M; Gan, L; Jiang, X; Langenickel, T; Mendonza, A; Neelakantham, S; Nguyen, J; Pal, P; Rajman, I; Rebello, S; Reynolds, C; Sunkara, G; Swan, T; Zhou, W | 1 |
| Alvey, CW; Krishnaswami, S; Menon, S; Petit, W; Riese, R; Shi, H; Wang, R | 1 |
| Dahiya, K; Dahiya, P; Dalal, M; Jain, S; Silan, V; Yadav, A | 1 |
| Gersten, J; Hsieh, J; Ricciotti, NA; Weiss, H | 1 |
| Ganie, MA; Mattoo, T; Mudassar, S; Rashid, F; Shekhar, C; Yousuf, SD; Zargar, MA | 1 |
| Albert, A; Appels, N; Coelingh Bennink, HJT; Fauser, BCJM; Laan, E; Termeer, HMM; Thijssen, JHH; van Lunsen, RHW; Zimmerman, Y | 1 |
| Blomberg, L; Dreber, A; Hirschberg, AL; Johannesson, M; Labrie, F; Ranehill, E; von Schoultz, B; Zethraeus, N | 1 |
| Buchanan, AM; Ford, SL; Gould, E; Huang, C; Lou, Y; Patel, P; Ritter, JM; Spreen, W; Trezza, C | 1 |
| Aleknaviciute, J; Bergink, V; Bouwkamp, CG; De Rijke, YB; Hoogendijk, WJG; Kooiman, CG; Kushner, SA; Tiemeier, H; Timmermans, M; Tulen, JHM; van der Kroeg, M; van Rossum, EFC; Wester, VL | 1 |
| Adeyanju, OA; Areola, ED; Michael, OS; Olatunji, LA; Soladoye, AO | 1 |
| de Zegher, F; Del Río, L; Díaz, M; Ibáñez, L; López-Bermejo, A; Pozo, ÓJ; Sebastiani, G | 1 |
| Aguilera, J; Carrascosa, JM; Castillo, G; Ferrándiz, C; Fuente, MJ; Richarz, NA | 1 |
| Michael, OS; Olatunji, LA | 1 |
| Adeyanju, OA; Olatunji, LA; Soetan, OA; Soladoye, AO | 1 |
| Edelman, AB; Hennebold, JD; Jensen, JT; McCrimmon, S; Messerle-Forbes, M; O'Donnell, A | 1 |
| Bar-Ilan, O; Dror, V; Elgart, A; Korver, T; Mimrod, D; Spiegelstein, O; Zur, AA | 1 |
| Olaniyi, KS; Olatunji, LA | 2 |
| Michael, OS; Olatunji, LA; Omolekulo, TE | 1 |
| Feng, T; Friedman, A; Mohamed, MF; Othman, AA; Trueman, S | 1 |
| Bujanda, L; Cosme Jimenez, Á; Gonzalez Canalizo, V; Medina Del Valle, A; Ortega Rezola, P; Sarasqueta Eizaguirre, C; Segues Merino, NM; Torrente Iranzo, S; Wong Arteta, J | 1 |
| Shenava, Y; Thwaites, A | 1 |
| Adeyanju, OA; Olatunji, LA | 1 |
| Grimmbacher, S; Hadji, P; Neulen, J; Schaudig, K; Schwenkhagen, A; Wiegratz, I | 1 |
| Anoka, NA; Lawrence, OA; Olufunmilayo, OM; Olufunto, BO | 1 |
| Etminan, M; Guo, MY; Khosrow-Khavar, F; Sodhi, M | 1 |
| Ampaw, L; Anderson, K; Begley, R; Kearney, BP; Mathias, A; Qin, A; Watkins, TR; Weng, W | 1 |
| Chaturvedula, A; Cicali, B; Cristofoletti, R; Hoechel, J; Lingineni, K; Schmidt, S; Vozmediano, V; Wendl, T; Wiesinger, H | 1 |
| Avis, M; Gahlemann, M; Guillén-Del-Castillo, A; Kreuter, M; Mack, SR; Marzin, K; Vonk, MC; Wind, S | 1 |
8 review(s) available for ethinyl estradiol-norgestrel combination and levonorgestrel
| Article | Year |
|---|---|
[What does the micropill bring?].
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Ovary; Progesterone Congeners; Risk | 1986 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Progesterone Congeners; Randomized Controlled Trials as Topic | 2002 |
Levonorgestrel as an emergency contraceptive drug.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Postcoital, Synthetic; Drug Administration Schedule; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Pregnancy; Treatment Failure | 2003 |
Continuous oral contraception. Strategies for managing breakthrough bleeding.
Topics: Aftercare; Contraceptives, Oral, Combined; Counseling; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Metrorrhagia; Nurse Practitioners; Patient Education as Topic; Primary Health Care | 2008 |
Mechanisms of action of hormonal emergency contraceptives.
Topics: Animals; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Models, Biological; Models, Statistical; Ovulation; Pregnancy; Pregnancy, Unwanted; Reproduction; Treatment Outcome | 2010 |
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.
Topics: Antidepressive Agents; Clinical Trials as Topic; Contraceptives, Oral, Combined; Depressive Disorder; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Placebo Effect; Premenstrual Syndrome | 2012 |
Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.
Topics: Androstenes; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipid Metabolism; Megestrol; Nandrolone; Venous Thromboembolism | 2015 |
Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique(®)): A Review of Its Use as an Oral Contraceptive.
Topics: Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Humans; Levonorgestrel; Menstrual Cycle | 2015 |
55 trial(s) available for ethinyl estradiol-norgestrel combination and levonorgestrel
| Article | Year |
|---|---|
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Topics: Adult; Apolipoproteins; Blood Glucose; Ceruloplasmin; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Pancuronium; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1992 |
Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Tablets | 1990 |
The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Topics: Adult; Contraceptive Agents, Female; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemia; Kenya; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norgestrel | 1990 |
Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Kinetics; Levonorgestrel; Norethindrone; Norgestrel; Random Allocation | 1986 |
The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Random Allocation | 1984 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. II-Subjective and objective measures of effects. An international comparative trial.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hemoglobins; Humans; Levonorgestrel; Norgestrel; Pregnancy; Vagina | 1981 |
A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
Topics: Adolescent; Adult; Chile; Contraceptives, Oral, Combined; Dominican Republic; Ecuador; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy; Sri Lanka; Sudan | 1993 |
Effect of two oral contraceptives with different ethinyl estradiol and levonorgestrel concentrations on the urinary excretion of biochemical vasoactive markers.
Topics: Adult; Analysis of Variance; Atrial Natriuretic Factor; Biomarkers; Cardiovascular System; Contraceptives, Oral, Combined; Cyclic GMP; Double-Blind Method; Epoprostenol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Kidney; Levonorgestrel; Peptide Fragments; Serotonin; Thromboxanes; Water-Electrolyte Balance | 2001 |
Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women.
Topics: Adult; Anticonvulsants; Contraceptives, Oral, Synthetic; Drug Interactions; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levetiracetam; Levonorgestrel; Piracetam | 2002 |
A multicenter, randomized study of an extended cycle oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Patient Compliance; Pregnancy | 2003 |
Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Metrorrhagia; Middle Aged; Nandrolone; Patient Satisfaction; Treatment Outcome; Young Adult | 2009 |
Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study.
Topics: Adolescent; Adult; Androstenes; Body Water; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Quality of Life; Single-Blind Method; Statistics, Nonparametric; Young Adult | 2010 |
An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables.
Topics: Adolescent; Adult; Carbohydrate Metabolism; Chlormadinone Acetate; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipid Metabolism; Young Adult | 2010 |
Treatment of premature ovarian failure trial: description of an ongoing clinical trial.
Topics: Adolescent; Adult; Bone Density; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Primary Ovarian Insufficiency; Prospective Studies; Treatment Outcome; Young Adult | 2010 |
A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia; Treatment Failure; Treatment Outcome | 2011 |
Treatment with liraglutide--a once-daily GLP-1 analog--does not reduce the bioavailability of ethinyl estradiol/levonorgestrel taken as an oral combination contraceptive drug.
Topics: Aged; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Cross-Over Studies; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Levonorgestrel; Liraglutide; Middle Aged; Postmenopause | 2011 |
Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Combined; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Linagliptin; Purines; Quinazolines; Young Adult | 2011 |
Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
Topics: Adult; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Glucose Tolerance Test; Hematologic Tests; Hemostasis; Humans; Levonorgestrel; Lipids; Middle Aged; Nandrolone; Thyroid Function Tests; Treatment Outcome; Young Adult | 2011 |
Assessment of the activity of an oral contraceptive on the levels of oxidative stress and changes in oxidative stress after co-treatment with two different types of physiological modulators with antioxidant action.
Topics: Adult; Antioxidants; Contraceptives, Oral, Combined; Cross-Over Studies; Dietary Supplements; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Oxidative Stress; Vitamins | 2011 |
A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Contraceptives, Oral, Combined; Double-Blind Method; Doxycycline; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Middle Aged; Treatment Outcome | 2012 |
The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Medication Adherence; Obesity; Patient Dropouts; Triglycerides; Young Adult | 2012 |
Predictors of noncompliance in an oral contraceptive clinical trial.
Topics: Adolescent; Adult; Biomarkers; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Educational Status; Ethinyl Estradiol; Female; Hispanic or Latino; Humans; Levonorgestrel; Medication Adherence; Obesity; Ovarian Follicle; Ovulation Inhibition; Patient Dropouts; Poverty; Single-Blind Method; United States; Young Adult | 2012 |
Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women.
Topics: Adolescent; Adult; Chromatography, Liquid; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Midazolam; Obesity; Prospective Studies; Tandem Mass Spectrometry; Young Adult | 2012 |
No clinically relevant drug-drug interactions when dalcetrapib is co-administered with a monophasic oral contraceptive (Microgynon® 30).
Topics: Adult; Amides; Anticholesteremic Agents; Biomarkers; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Interactions; Esters; Ethinyl Estradiol; Female; Follicle Stimulating Hormone, Human; Humans; Levonorgestrel; Luteinizing Hormone; Ovulation Inhibition; Progesterone; Sulfhydryl Compounds; Young Adult | 2012 |
The effect of lersivirine, a next-generation NNRTI, on the pharmacokinetics of midazolam and oral contraceptives in healthy subjects.
Topics: Adolescent; Adult; Biotransformation; Contraceptives, Oral; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Male; Metabolic Clearance Rate; Midazolam; Middle Aged; Nitriles; Pyrazoles; Reverse Transcriptase Inhibitors; Young Adult | 2012 |
Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 year.
Topics: Adolescent; Adult; Contraception Behavior; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Intention to Treat Analysis; Levonorgestrel; Lost to Follow-Up; Medication Adherence; Menstruation; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Precision Medicine; Severity of Illness Index; United Kingdom; Young Adult | 2013 |
Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Drug Substitution; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Sexual Dysfunction, Physiological; Young Adult | 2013 |
An ethinyl estradiol-levonorgestrel containing oral contraceptive does not alter cytochrome P4502C9 in vivo activity.
Topics: Adolescent; Adult; Aryl Hydrocarbon Hydroxylases; Contraceptives, Oral, Combined; Cytochrome P-450 CYP2C9; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Substrate Specificity; Tolbutamide; Young Adult | 2014 |
Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women.
Topics: Adult; Anticonvulsants; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Interactions; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Progesterone; Pyrrolidinones; Young Adult | 2013 |
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethnicity; Female; Humans; Levonorgestrel; Obesity; Patient Compliance; Pregnancy; Transdermal Patch; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
Topics: Adolescent; Adult; Double-Blind Method; Drug Combinations; Dysmenorrhea; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Time Factors; Treatment Outcome; Young Adult | 2014 |
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Obesity; Patient Outcome Assessment; Transdermal Patch; Young Adult | 2015 |
No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.
Topics: Adult; Anti-Anxiety Agents; Contraceptives, Oral, Combined; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endometrium; Estradiol; Ethinyl Estradiol; Female; Herb-Drug Interactions; Humans; Lavandula; Levonorgestrel; Oils, Volatile; Ovarian Follicle; Patient Compliance; Plant Oils; Progesterone; Sex Hormone-Binding Globulin; Young Adult | 2014 |
Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants.
Topics: Adult; Anticoagulants; Area Under Curve; Blood Coagulation; Canagliflozin; Cardiotonic Agents; Contraceptives, Oral, Combined; Cross-Over Studies; Digoxin; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Interactions; Ethinyl Estradiol; Female; Glucosides; Half-Life; Healthy Volunteers; Humans; Hypoglycemic Agents; International Normalized Ratio; Levonorgestrel; Male; Metabolic Clearance Rate; Middle Aged; Polypharmacy; Risk Assessment; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Warfarin; Young Adult | 2015 |
Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers.
Topics: Administration, Oral; Adolescent; Adult; Aminoisobutyric Acids; Area Under Curve; Bilirubin; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Leucine; Levonorgestrel; Oligopeptides; Proline; Protease Inhibitors; Quinolines; Thiazoles; Viral Nonstructural Proteins; Young Adult | 2015 |
Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menorrhagia; Menstrual Cycle; Metrorrhagia; Norpregnenes; Patient Dropouts; Progestins; Transdermal Patch; United States; Young Adult | 2015 |
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; New South Wales; Patient Education as Topic; Patient Satisfaction; Self Care; Young Adult | 2015 |
A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovarian Follicle; Ovulation Inhibition; Philadelphia; Progesterone; Time Factors; Washington; Young Adult | 2015 |
Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill.
Topics: Adolescent; Adult; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Patient Compliance; Reproducibility of Results; Self Report; Transdermal Patch; Young Adult | 2015 |
New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study.
Topics: Adhesiveness; Adolescent; Adult; Contraceptives, Oral, Combined; Dermatitis, Contact; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Research Personnel; Transdermal Patch; Young Adult | 2015 |
Effect of pradigastat, a diacylglycerol acyltransferase 1 inhibitor, on the pharmacokinetics of a combination oral contraceptive in healthy female subjects.
Topics: Acetates; Adult; Aminopyridines; Area Under Curve; Contraceptives, Oral, Combined; Diacylglycerol O-Acyltransferase; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Levonorgestrel; Metabolic Clearance Rate; Risk Assessment; Risk Factors; Young Adult | 2015 |
Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial.
Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovary; Ovulation Inhibition; Progesterone; Ultrasonography | 2015 |
Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Excitatory Amino Acid Antagonists; Female; Healthy Volunteers; Humans; Indoles; Levonorgestrel; Metabolic Clearance Rate; Models, Biological; Receptor, Metabotropic Glutamate 5; Young Adult | 2015 |
The effect of combined hormonal contraceptives use on brain reactivity during response inhibition.
Topics: Adult; Brain; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Evoked Potentials; Female; Functional Neuroimaging; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Levonorgestrel; Magnetic Resonance Imaging; Neural Inhibition; Young Adult | 2016 |
Pharmacokinetic drug-drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel-ethinyl estradiol in healthy subjects.
Topics: Adolescent; Adult; Aminobutyrates; Angiotensin Receptor Antagonists; Area Under Curve; Biphenyl Compounds; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Male; Metformin; Middle Aged; Omeprazole; Tetrazoles; Valsartan; Young Adult | 2016 |
Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Young Adult | 2016 |
Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; India; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; Patient Acceptance of Health Care; Severity of Illness Index | 2016 |
Effect of Extended 30 μg Ethinyl Estradiol with Continuous Low-Dose Ethinyl Estradiol and Cyclic 20 μg Ethinyl Estradiol Oral Contraception on Adolescent Bone Density: A Randomized Trial.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Child; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lumbar Vertebrae | 2016 |
Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Dehydroepiandrosterone; Double-Blind Method; Down-Regulation; Drug Combinations; Endocrine Glands; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Netherlands; Reproducibility of Results; Sex Hormone-Binding Globulin; Solubility; Testosterone; Young Adult | 2017 |
Combined Oral Contraceptives and Sexual Function in Women-a Double-Blind, Randomized, Placebo-Controlled Trial.
Topics: Adolescent; Adult; Arousal; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Lost to Follow-Up; Patient Dropouts; Patient Satisfaction; Pleasure; Psychiatric Status Rating Scales; Severity of Illness Index; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Stress, Psychological; Sweden; Young Adult | 2016 |
Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.
Topics: Adolescent; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Intra-Abdominal Fat; Levonorgestrel; Metformin; Oligomenorrhea; Ovulation; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Thiazolidinediones | 2017 |
The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Headache; Humans; Immunologic Factors; Levonorgestrel; Quinolones; Therapeutic Equivalency; Young Adult | 2019 |
The JAK1 Inhibitor Upadacitinib Has No Effect on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol: A Study in Healthy Female Subjects.
Topics: Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Delayed-Action Preparations; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase Inhibitors; Levonorgestrel; Middle Aged; Young Adult | 2019 |
Extended-cycle versus conventional treatment with a combined oral contraceptive containing ethinylestradiol (30 μg) and levonorgestrel (150 μg) in a randomized controlled trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Treatment Outcome; Young Adult | 2020 |
Lack of Drug-Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy Volunteers.
Topics: Adult; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Janus Kinase 1; Janus Kinase Inhibitors; Levonorgestrel; Middle Aged; Pyridines; Triazoles; Young Adult | 2021 |
59 other study(ies) available for ethinyl estradiol-norgestrel combination and levonorgestrel
| Article | Year |
|---|---|
Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
Topics: Administration, Oral; Adolescent; Adult; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Protein Binding; Sex Hormone-Binding Globulin; Time Factors | 1992 |
Effects of low-dose oral contraceptives on female whole saliva.
Topics: Adult; Buffers; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Male; Menstrual Cycle; Menstruation; Norgestrel; Norpregnenes; Ovulation; Progesterone Congeners; Saliva; Salivary Proteins and Peptides | 1991 |
Possible estrogen-induced NMS.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Neuroleptic Malignant Syndrome; Norgestrel; Schizophrenia, Paranoid | 1989 |
Oral contraception, 1986. Currently available formulations.
Topics: Canada; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Drug Combinations; Drug Compounding; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; France; Humans; Levonorgestrel; Norethindrone; Norgestrel; Stereoisomerism; United States | 1986 |
[Effect of the estrogen-progesterone combination preparations gravistat and Minisiston on carbohydrate metabolism].
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dietary Carbohydrates; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Norgestrel | 1987 |
Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
Topics: Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation; Nausea; Norgestrel; Uterine Hemorrhage | 1983 |
The effect of cotrimoxazole on oral contraceptive steroids in women.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovulation; Patient Compliance; Progesterone | 1984 |
Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Topics: Adult; Antithrombins; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Drug Combinations; Drug Implants; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel | 1984 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. I-Use effectiveness. An international comparative trial.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Leukorrhea; Levonorgestrel; Menstruation Disturbances; Norgestrel; Pregnancy; Statistics as Topic; Vagina | 1981 |
A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. III-Menstrual patterns. An international comparative trial.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norgestrel; Vagina | 1981 |
Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Carrier Proteins; Complement System Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy Proteins; Protease Inhibitors; Serum Albumin; Sex Hormone-Binding Globulin; Steroids; Transcortin | 1993 |
Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
Topics: Adolescent; Body Weight; Case-Control Studies; Chi-Square Distribution; Child; Condoms; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Implants; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Norgestrel; Regression Analysis | 1995 |
[The clinico-morphological and cytological characteristics of the ecto- and endocervix with the use of the oral contraceptive triregol].
Topics: Adolescent; Adult; Biopsy; Cervix Uteri; Colposcopy; Contraceptives, Oral, Combined; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Histocytochemistry; Humans; Levonorgestrel; Time Factors; Uterine Cervical Erosion; Vaginal Smears | 1993 |
Hormonal effects of Depo-Provera in cervical smears: a comparison with Triphasil and postmenopausal effects.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cervix Uteri; Contraceptive Agents, Female; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Vaginal Smears | 2002 |
[Experimental study on estrogenic function of triphasic contraceptive tablets].
Topics: Animals; Contraceptives, Oral, Synthetic; Epithelial Cells; Estrogens, Non-Steroidal; Ethinyl Estradiol-Norgestrel Combination; Female; Levonorgestrel; Mice; Random Allocation; Receptors, Estrogen; Vagina | 2003 |
Effects of making emergency contraception available without a physician's prescription: a population-based study.
Topics: Adolescent; Adult; Age Distribution; Algorithms; British Columbia; Child; Contraceptives, Postcoital, Hormonal; Databases as Topic; Drug Prescriptions; Drug Utilization; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Medical Record Linkage; Medical Records Systems, Computerized; Middle Aged; Pharmacies | 2005 |
Contraceptive-related cerebral venous thrombosis with profuse vaginal bleed.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Intrauterine Devices, Medicated; Lateral Sinus Thrombosis; Levonorgestrel; Menorrhagia | 2005 |
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia | 2008 |
By the way, doctor. Some of my friends are excited about the new oral contraceptive that eliminates periods. But it worries me. Does anyone know what happens when you stop menstruating for a long time? It just seems unnatural.
Topics: Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation | 2007 |
Menorrhagia and severe menstrual pain related to the use of adalimumab in a psoriatic.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Contraceptives, Oral, Combined; Drug Combinations; Drug Labeling; Dysmenorrhea; Etanercept; Ethinyl Estradiol; Female; Humans; Immunoglobulin G; Immunologic Factors; Levonorgestrel; Menorrhagia; Obesity, Morbid; Product Surveillance, Postmarketing; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha; United Kingdom; United States | 2008 |
Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Metrorrhagia; Retrospective Studies; Young Adult | 2009 |
Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone/EE vs. a second-generation oral contraceptive containing levonorgestrel/EE.
Topics: Angiotensinogen; Blood Coagulation Factors; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Discriminant Analysis; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norprogesterones; Risk; Sex Hormone-Binding Globulin; Thrombosis; Triglycerides | 2012 |
Ethinylestradiol and levonorgestrel preparations on the Belgian market: a comparative study.
Topics: Belgium; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Levonorgestrel; Reproducibility of Results; Solubility; Spectrophotometry, Ultraviolet; Tablets, Enteric-Coated | 2012 |
Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women; cross-sectional study.
Topics: Adolescent; Adult; Androstenes; Brazil; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; E-Selectin; Ethinyl Estradiol; Female; Humans; Intercellular Adhesion Molecule-1; Levonorgestrel; Vascular Cell Adhesion Molecule-1 | 2012 |
Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
Topics: Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Levonorgestrel; Propylene Glycols; Sphingosine | 2012 |
Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.
Topics: Adolescent; Adult; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Progesterone; Prospective Studies | 2013 |
Emergency contraception: no. 280 (replaces No. 131, August 2003).
Topics: Contraception, Postcoital; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Drug Combinations; Ethinyl Estradiol; Female; Health Services Accessibility; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Pregnancy, Unplanned | 2013 |
Women's experiences with tailored use of a combined oral contraceptive: a qualitative study.
Topics: Adolescent; Adult; Contraception; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Middle Aged; Randomized Controlled Trials as Topic | 2013 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |
A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens.
Topics: Adolescent; Adult; Biological Availability; Computer Simulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Middle Aged; Models, Biological; Nonlinear Dynamics; Young Adult | 2014 |
Recurrent peritoneal inclusion cysts successfully treated with oral contraceptives: a report of two cases.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cysts; Drug Combinations; Ethinyl Estradiol; Female; Gynecologic Surgical Procedures; Humans; Levonorgestrel; Middle Aged; Peritoneal Diseases; Recurrence; Sclerotherapy; Tissue Adhesions | 2014 |
Decreased allopregnanolone induced by hormonal contraceptives is associated with a reduction in social behavior and sexual motivation in female rats.
Topics: Agonistic Behavior; Anhedonia; Animals; Cerebral Cortex; Contraceptives, Oral, Hormonal; Depression; Drug Combinations; Ethinyl Estradiol; Female; Levonorgestrel; Maze Learning; Motivation; Pregnanolone; Rats; Rats, Sprague-Dawley; Sexual Behavior, Animal; Social Behavior; Swimming | 2014 |
Endometrial cancer in a woman with 46,XY pure gonadal dysgenesis.
Topics: Adult; Drug Combinations; Endometrial Neoplasms; Ethinyl Estradiol; Female; Gonadal Dysgenesis, 46,XY; Hormone Replacement Therapy; Hormones; Humans; Incidental Findings; Levonorgestrel; Ovariectomy; Treatment Outcome | 2015 |
Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel.
Topics: Aged; Area Under Curve; Blood Glucose; Contraceptives, Oral, Combined; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Glucagon-Like Peptides; Glycated Hemoglobin; Half-Life; Humans; Hypoglycemic Agents; Levonorgestrel; Metabolic Clearance Rate; Middle Aged; Postmenopause | 2015 |
Estimating systemic exposure to ethinyl estradiol from an oral contraceptive.
Topics: Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Young Adult | 2015 |
A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque (Macaca nemestrina) model.
Topics: Animals; Contraceptives, Oral, Combined; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; HIV Infections; Levonorgestrel; Macaca nemestrina; Menstrual Cycle; Mucous Membrane; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Vagina | 2015 |
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.
Topics: Adiponectin; Adipose Tissue; Adult; Androstenes; Anthropometry; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Egypt; Ethinyl Estradiol; Female; Humans; Leptin; Levonorgestrel; Norpregnenes; Resistin; Risk Factors | 2015 |
Oral contraceptive use and saliva diurnal pattern of metabolic steroid hormones in young healthy women.
Topics: Circadian Rhythm; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Menstrual Cycle; Saliva; Testosterone; Young Adult | 2015 |
Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
Topics: Contraception Behavior; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Medication Adherence; Patient Satisfaction; Pregnancy; United States | 2016 |
Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system.
Topics: Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Humans; Levonorgestrel; Norgestrel; Oximes | 2015 |
Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-α Levels in Women with Polycystic Ovary Syndrome: A Pilot Study.
Topics: Adolescent; Adult; Chemokine CCL2; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intercellular Adhesion Molecule-1; Levonorgestrel; Pilot Projects; Polycystic Ovary Syndrome; Tumor Necrosis Factor-alpha; Young Adult | 2017 |
Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.
Topics: Administration, Oral; Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone, Human; Healthy Volunteers; HIV Integrase Inhibitors; Humans; Levonorgestrel; Luteinizing Hormone; Progesterone; Pyridones; Young Adult | 2017 |
The levonorgestrel-releasing intrauterine device potentiates stress reactivity.
Topics: Adrenocorticotropic Hormone; Adult; Contraceptive Agents, Female; Cross-Sectional Studies; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Intrauterine Devices; Levonorgestrel; Pituitary-Adrenal System; Saliva; Young Adult | 2017 |
Anti-inflammatory and antithrombotic effects of nicotine exposure in oral contraceptive-induced insulin resistance are glucocorticoid-independent.
Topics: Animals; Anti-Inflammatory Agents; Blood Viscosity; Contraceptives, Oral; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fibrinolytic Agents; Glucocorticoids; Insulin Resistance; Levonorgestrel; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley | 2017 |
Phototoxic reaction to a combined oral contraceptive (levonorgestrel/ethinylestradiol).
Topics: Adult; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Photosensitizing Agents; Skin; Spectrophotometry; Ultraviolet Rays | 2017 |
Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy.
Topics: Administration, Oral; Aldosterone; Animals; Biomarkers; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Glycogen Synthase Kinase 3; Heart; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Levonorgestrel; Myocardium; Nicotine; Nicotinic Agonists; Plasminogen Activator Inhibitor 1; Prediabetic State; Random Allocation; Rats, Wistar | 2018 |
Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Eating; Estradiol; Estrogens; Ethinyl Estradiol; Fasting; Female; Glycogen Synthase Kinase 3; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Levonorgestrel; Mineralocorticoids; Obesity; Rats; Rats, Wistar; Triglycerides | 2018 |
Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: A prospective cohort study.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Levonorgestrel; Luteinizing Hormone; Norpregnadienes; Ovarian Follicle; Ovulation; Progesterone; Prospective Studies; Ultrasonography | 2018 |
Oral ethinylestradiol-levonorgestrel attenuates cardiac glycogen and triglyceride accumulation in high fructose female rats by suppressing pyruvate dehydrogenase kinase-4.
Topics: Administration, Oral; Animals; Drug Combinations; Ethinyl Estradiol; Female; Fructose; Glycogen; Levonorgestrel; Myocardium; Protein Kinases; Rats, Wistar; Triglycerides | 2019 |
Sodium acetate improves disrupted glucoregulation and hepatic triglyceride content in insulin-resistant female rats: involvement of adenosine deaminase and dipeptidyl peptidase-4 activities.
Topics: Adenosine Deaminase; Animals; Dipeptidyl Peptidase 4; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Insulin Resistance; Levonorgestrel; Liver; Rats, Wistar; Sodium Acetate; Triglycerides; Uric Acid; Xanthine Oxidase | 2019 |
Short article: Hormone therapy for severe gastrointestinal bleeding due to multiple angiodysplastic lesions.
Topics: Aged; Aged, 80 and over; Anemia; Angiodysplasia; Blood Transfusion; Drug Combinations; Ethinyl Estradiol; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hemoglobins; Humans; Length of Stay; Levonorgestrel; Male; Patient Admission; Recurrence; Severity of Illness Index; Time Factors; Treatment Outcome | 2019 |
A fractured arm and forgotten contraceptive implant.
Topics: Accidental Falls; Adult; Contraceptive Agents, Female; Device Removal; Drug Combinations; Drug Implants; Ethinyl Estradiol; Female; Foreign-Body Migration; Humans; Humeral Fractures; Levonorgestrel; Ultrasonography, Interventional | 2019 |
Oral ethinylestradiol-levonorgestrel normalizes fructose-induced hepatic lipid accumulation and glycogen depletion in female rats.
Topics: Administration, Oral; Animals; Antioxidants; Blood Glucose; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fructose; Glucosephosphate Dehydrogenase; Glycogen; Hyperinsulinism; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Lipid Peroxidation; Liver; Protein Kinases; Rats; Rats, Wistar; Uric Acid | 2019 |
Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone.
Topics: Androstenes; Animals; Blood Glucose; Body Weight; Contraceptives, Oral; Corticosterone; Drug Combinations; Ethinyl Estradiol; Female; Insulin; Insulin-Secreting Cells; Levonorgestrel; Rats | 2019 |
Insulin resistance and depressed cardiac G6PD activity induced by glucocorticoid exposure during pregnancy are attenuated by maternal estrogen-progestin therapy.
Topics: Animals; Contraceptives, Oral, Combined; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Glucocorticoids; Glucosephosphate Dehydrogenase; Insulin Resistance; Levonorgestrel; Maternal-Fetal Exchange; Myocardium; Pregnancy; Progestins; Rats, Wistar | 2020 |
Risk of sexual dysfunction with progestin-based contraceptives in women of child-bearing age.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged; Progestins; Sexual Dysfunction, Physiological; Young Adult | 2021 |
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.
Topics: Adult; Alkynes; Benzoxazines; Body Mass Index; Carbamazepine; Clarithromycin; Computer Simulation; Contraceptives, Oral, Combined; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Itraconazole; Levonorgestrel; Models, Biological; Obesity; Rifampin; Sex Hormone-Binding Globulin | 2021 |
A Drug-Drug Interaction Study to Investigate the Effect of Nintedanib on the Pharmacokinetics of Microgynon (Ethinylestradiol and Levonorgestrel) in Female Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.
Topics: Antineoplastic Agents; Area Under Curve; Contraceptive Agents, Hormonal; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Europe; Female; Humans; Indoles; Levonorgestrel; Lung Diseases, Interstitial; Middle Aged; Scleroderma, Systemic; United States | 2022 |